---
title: "Biotechnology Value Trading Fund OS LP — Ownership Dossier"
canonical: https://whiteintel.dev/entity/5b96dfc9-0dbb-51e4-bb93-2b04087dd95d
json: https://whiteintel.dev/api/public/dossier/5b96dfc9-0dbb-51e4-bb93-2b04087dd95d
identifier: sec:0001660683
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Biotechnology Value Trading Fund OS LP

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001660683`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/5b96dfc9-0dbb-51e4-bb93-2b04087dd95d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/5b96dfc9-0dbb-51e4-bb93-2b04087dd95d  

## Ownership & control

### Holdings / subsidiaries

- **XOMA Royalty Corp** (director) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673
- **Olema Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **Olema Pharmaceuticals, Inc.** (director) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **XOMA Royalty Corp** (other) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673
- **MoonLake Immunotherapeutics** (other) — https://whiteintel.dev/entity/9809d1b9-2d89-5192-9d9c-cb0f9428a934
- **Kymera Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7
- **MoonLake Immunotherapeutics** (director) — https://whiteintel.dev/entity/9809d1b9-2d89-5192-9d9c-cb0f9428a934
- **Olema Pharmaceuticals, Inc.** (other) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **Kymera Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7
- **IMMUNIC, INC.** (director) — https://whiteintel.dev/entity/2e503801-64a9-5687-a6d5-8453384d5c51
- **IMMUNIC, INC.** (other) — https://whiteintel.dev/entity/2e503801-64a9-5687-a6d5-8453384d5c51
- **Repare Therapeutics Inc.** (other) — https://whiteintel.dev/entity/a4f328c3-615d-5e8c-a160-a31e92a6143d
- **ESSA PHARMA INC.** (other) — https://whiteintel.dev/entity/a496bea7-7d30-5e59-8841-ba61e99e06cf
- **CRESCENT BIOPHARMA, INC.** (other) — https://whiteintel.dev/entity/af95539c-09bd-5667-a03e-8cd2e3451859
- **Allakos Inc.** (other) — https://whiteintel.dev/entity/5439ff82-19b3-51bc-9ac4-c6f7101c71e3
- **Eledon Pharmaceuticals, Inc.** (other) — https://whiteintel.dev/entity/52b9f178-e91f-55f5-9c71-d0920cd35871
- **PALVELLA THERAPEUTICS, INC.** (other) — https://whiteintel.dev/entity/3ef13500-65c6-5a7a-bc7c-5944649c1abb
- **4D Molecular Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/d72c9d0a-737e-53ec-b488-9dc05920e9a3
- **Third Harmonic Bio, Inc.** (other) — https://whiteintel.dev/entity/e1b6fe48-1324-5dbb-bd90-38bb4c119af2
- **RAIN ONCOLOGY INC.** (director) — https://whiteintel.dev/entity/54053b30-6edd-583c-8763-b27cba56a7cd
- **RAIN ONCOLOGY INC.** (other) — https://whiteintel.dev/entity/54053b30-6edd-583c-8763-b27cba56a7cd
- **enGene Holdings Inc.** (other) — https://whiteintel.dev/entity/c9dc64b2-8894-5ef5-a845-77724013327b
- **POINT BIOPHARMA GLOBAL INC.** (other) — https://whiteintel.dev/entity/43e8e7b1-fb25-50ef-88ea-ea634f8c1919
- **CELL THERAPEUTICS INC** (other) — https://whiteintel.dev/entity/818d7969-e7e1-55ba-b25f-9085b030a3bf
- **Structure Therapeutics Inc.** (other) — https://whiteintel.dev/entity/4d402256-4ab9-5146-a9e3-6950aee1cf14
- **XOMA Royalty Corp** (director) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673
- **CELL THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/818d7969-e7e1-55ba-b25f-9085b030a3bf
- **Cullinan Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/e103e223-6420-5795-bce5-450261fac1da
- **RAIN ONCOLOGY INC.** (directorother) — https://whiteintel.dev/entity/54053b30-6edd-583c-8763-b27cba56a7cd
- **XOMA Royalty Corp** (directorother) — https://whiteintel.dev/entity/879bcb76-24e5-5154-a262-697323c83673
- **CELL THERAPEUTICS INC** (directorother) — https://whiteintel.dev/entity/818d7969-e7e1-55ba-b25f-9085b030a3bf
- **Kymera Therapeutics, Inc.** (directorother) — https://whiteintel.dev/entity/ee121c9c-c882-5afe-93fb-7abe6b4ca8d7
- **Olema Pharmaceuticals, Inc.** (directorother) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **MoonLake Immunotherapeutics** (directorother) — https://whiteintel.dev/entity/9809d1b9-2d89-5192-9d9c-cb0f9428a934
- **Verastem, Inc.** (other) — https://whiteintel.dev/entity/48e38b21-bb92-51a5-bacf-892c060d8dd6
- **Merus N.V.** (other) — https://whiteintel.dev/entity/94da0ca6-a73e-5895-83fb-b50de1f38026
- **FIVE PRIME THERAPEUTICS INC** (other) — https://whiteintel.dev/entity/9aff28e2-4669-58d2-ac70-a8796893d4c8
- **CytomX Therapeutics, Inc.** (other) — https://whiteintel.dev/entity/6548f99c-6754-59ef-a2b1-ed7cd21f6d1b
- **IDEAYA Biosciences, Inc.** (other) — https://whiteintel.dev/entity/740ea9d8-4732-5954-9126-66106b8f76b5
- **DISCOVERY PARTNERS INTERNATIONAL INC** (other) — https://whiteintel.dev/entity/3ae609cf-fccd-58c2-960d-ef36bf02bf22
- **CYTOKINETICS INC** (other) — https://whiteintel.dev/entity/0eb385f6-49c6-5406-ba0c-13179011e29b
- **PRINCIPIA BIOPHARMA INC.** (other) — https://whiteintel.dev/entity/6a36d913-a2d3-50be-abc9-858acd647053
- **CALITHERA BIOSCIENCES, INC.** (other) — https://whiteintel.dev/entity/62e5aa07-2012-5418-a486-e6d032e5e66f
- **CONCERT PHARMACEUTICALS INC** (other) — https://whiteintel.dev/entity/3e2da9ca-0d84-5cb7-9b84-e4195d1748f4
- **IMMUNE DESIGN CORP.** (other) — https://whiteintel.dev/entity/90dcaf96-fc16-5591-8d81-164c9a7e0cff
- **ARQULE INC** (other) — https://whiteintel.dev/entity/fd5da0c7-0a00-5a43-af99-33ea05777d0a
- **Syndax Pharmaceuticals Inc** (other) — https://whiteintel.dev/entity/6bf1b313-1d8f-5b91-99ed-9315f51eef71
- **Xenon Pharmaceuticals Inc.** (other) — https://whiteintel.dev/entity/3e20a2da-c4ad-5d3e-8c87-9dd6b2938172
- **Regulus Therapeutics Inc.** (other) — https://whiteintel.dev/entity/4fb1e8db-c587-5dce-8215-4c53445c8050
- **ALPINE IMMUNE SCIENCES, INC.** (other) — https://whiteintel.dev/entity/ad945a36-f186-59fa-b801-2b39506284f6
- **DISCOVERY PARTNERS INTERNATIONAL INC** (tenpercentowner) — https://whiteintel.dev/entity/3ae609cf-fccd-58c2-960d-ef36bf02bf22
- **BIOMIRA CORP** (tenpercentowner) — https://whiteintel.dev/entity/82b3cb4c-4e01-50d7-99f6-0eb90587fb53
- **CELL THERAPEUTICS INC** (tenpercentownerother) — https://whiteintel.dev/entity/818d7969-e7e1-55ba-b25f-9085b030a3bf
- **BIOMIRA CORP** (other) — https://whiteintel.dev/entity/82b3cb4c-4e01-50d7-99f6-0eb90587fb53

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Biotechnology Value Trading Fund OS LP**. Human view: https://whiteintel.dev/entity/5b96dfc9-0dbb-51e4-bb93-2b04087dd95d · Structured JSON: https://whiteintel.dev/api/public/dossier/5b96dfc9-0dbb-51e4-bb93-2b04087dd95d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._